The beriberi analogy to myocardial infarction.

Two pandemics of heart attack deaths have plagued the world's population during the past 130 years. The first pandemic, induced by beriberi, was caused by the industrial revolution altering the nutritional composition of rice. By 1892 a simple working knowledge, then at hand, could have terminated the beriberi plague; however, orthodox medicine being then enchanted with the false concept that all disease was caused by germs, permitted millions of Asians to die needlessly of beriberi by refusing to tell them to eat rice bran or to drink rice bran tea. A second pandemic of heart attack deaths, called myocardial infarction (MI), struck the developed nations of the Western World in full force after 1930. As a hypothesis, it is suggested that this MI pandemic, still raging today, was caused by a change in food processing that occurred after 1920, when the new oil seed industry introduced into our food three greatly harmful lipid substances. The unnatural trans-trans isomer of linoleic acid, which had never been in human food prior to 1920 and which entered our food in margarines and refined oils, blocked the conversion of natural cis-cis linoleic acid to prostaglandin E1, which tends to prevent MI, both by acting as a vasodilator and by minimizing platelet aggregation. Harmful lactones were also introduced into our food, increasing the risk of MI by decreasing the fibrinolytic activity of our blood. The oil seed industry also introduced into our diet free radical lipid peroxides that make the myocardium more vulnerable to infarction. It is suggested that except for the one in 500 of us who is afflicted by familial hypercholesterolemia, the cholesterol concept of MI is as false today as was the concept in 1900 that germs caused beriberi. It is further suggested that a working knowledge is at hand today that can make death from MI just as rare as death is now from a beriberi-induced heart attack.

[1]  J. Gofman,et al.  Blood Lipids and Human Atherosclerosis , 1950, Circulation.

[2]  R. Peters ADDRESSES AND ORIGINAL ARTICLESTHE BIOCHEMICAL LESION IN VITAMIN B1 DEFICIENCY: APPLICATION OF MODERN BIOCHEMICAL ANALYSIS IN ITS DIAGNOSIS☆ , 1936 .

[3]  G. Friesinger,et al.  PLATELET AGGREGATES IN PERIPHERAL AND CORONARY-SINUS BLOOD IN PATIENTS WITH SPONTANEOUS CORONARY-ARTERY SPASM , 1980, The Lancet.

[4]  E. Benditt The origin of atherosclerosis. , 1977, Scientific American.

[5]  R. O’meara,et al.  Cytological observations on carcinoma , 1958, Irish journal of medical science.

[6]  S. Chierchia,et al.  Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. , 1978, The New England journal of medicine.

[7]  Sinclair Hm Deficiency of essential fatty acids and atherosclerosis, etcetera. , 1956 .

[8]  J. McDonald,et al.  Inhibition of human platelet cyclooxygenase by alpha-tocopherol. , 1980, Prostaglandins and medicine.

[9]  I. Wright,et al.  Report of the Committee for the Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction; a progress report on the statistical analysis of the first 800 cases studied by this committee. , 1948, American heart journal.

[10]  M. Oliver SERUM CHOLESTEROL-THE KNAVE OF HEARTS AND THE JOKER , 1981, The Lancet.

[11]  P. B. Oliva,et al.  Arteriographic Evidence of Coronary Arterial Spasm in Acute Myocardial Infarction , 1977, Circulation.

[12]  J. Mcnee The Clinical Syndrome of Thrombosis of the Coronary Arteries , 1925 .

[13]  L. Mcdonald,et al.  Changes in coagulability of the blood during various phases of ischaemic heart-disease. , 1959, Lancet.

[14]  L. Michaels CANCER INCIDENCE AND MORTALITY IN PATIENTS HAVING ANTICOAGULANT THERAPY. , 1964, Lancet.

[15]  M. Ruckstuhl,et al.  Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. , 1979, Biochemical pharmacology.

[16]  E. Wills,et al.  MECHANISMS OF LIPID PEROXIDE FORMATION IN TISSUES. ROLE OF METALS AND HAEMATIN PROTEINS IN THE CATALYSIS OF THE OXIDATION UNSATURATED FATTY ACIDS. , 1965, Biochimica et biophysica acta.

[17]  D F Horrobin,et al.  A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2. , 1980, Medical hypotheses.

[18]  P. Owren CORONARY THROMBOSIS: ITS MECHANISM AND POSSIBLE PREVENTION BY LINOLENIC ACID. , 1965, Annals of internal medicine.

[19]  L. Solberg,et al.  Atherosclerosis in persons with coronary heart disease. , 1968, Laboratory investigation; a journal of technical methods and pathology.

[20]  R. Chakrabarti,et al.  Fibrinolytic activity related to age in survivors of myocardial infarction. , 1966, Lancet.

[21]  E. Arnesen,et al.  The Tromsø Heart Study , 1983 .

[22]  M. Barrett,et al.  Vitamin E inhibits arachidonic acid induced mortality and renal IgM deposition in rabbits. , 1980, Prostaglandins and medicine.

[23]  K. Mccully,et al.  Homocysteine theory of arteriosclerosis. , 1975, Atherosclerosis.

[24]  J. Sullivan IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK , 1981, The Lancet.

[25]  T. Ariga,et al.  PLATELET AGGREGATION INHIBITOR IN GARLIC , 1981, The Lancet.

[26]  S. Dyke THE BLOOD PLATELETS AND THEIR PLACE IN MEDICINE. , 1924 .

[27]  A. Shaper,et al.  Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda. , 1959, Lancet.

[28]  I. Gore,et al.  Comparison of aortic atherosclerosis in the United States, Japan, and Guatemala. , 1959, The American journal of clinical nutrition.

[29]  H. Griswold,et al.  PROPHYLACTIC ANTICOAGULANT THERAPY FOR CORONARY ARTERY DISEASE. A SEVEN-YEAR CONTROLLED STUDY. , 1964, JAMA.

[30]  A. Marcus The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. , 1978, Journal of lipid research.

[31]  G E Felton,et al.  Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patients. , 1980, Medical hypotheses.

[32]  R. O'Neal,et al.  Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism. A geographic study based on autopsies in Uganda. East Africa and St. Louis, U.S.A. , 1960, The American journal of cardiology.

[33]  A. Makheja,et al.  INHIBITION OF PLATELET AGGREGATION AND THROMBOXANE SYNTHESIS BY ONION AND GARLIC , 1979, The Lancet.

[34]  H. Wright,et al.  Changes in the adhesiveness of blood platelets following parturition and surgical operations , 1942 .

[35]  T. Anderson Nutritional muscular dystrophy and human myocardial infarction. , 1973, Lancet.

[36]  J. Mann,et al.  Prudent diet: effect on moderately severe hyperlipidaemia. , 1982, British medical journal.

[37]  R. O’meara Coagulative properties of cancers , 1958, Irish Journal of Medical Science.

[38]  J. Folkman,et al.  Protamine is an inhibitor of angiogenesis , 1982, Nature.

[39]  A. Willis,et al.  Antithrombotic potential of dihomo-gamma-linolenic acid in man. , 1977, British medical journal.

[40]  V. Kakkar,et al.  Pyridoxal 5'-phosphate--a new physiological inhibitor of blood coagulation and platelet function. , 1979, Biochemical pharmacology.

[41]  S. Moore Platelet aggregation secondary to coronary obstruction. , 1976, Circulation.

[42]  H. E. Burke,et al.  BLOOD COAGULATION AS STUDIED BY INTRAVENOUS INJECTION OF TISSUE EXTRACT , 1926 .

[43]  Rudin Do The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra. , 1981 .

[44]  D. Thelle,et al.  THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.

[45]  J. Vane,et al.  HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION , 1977, The Lancet.